← Eichor
Study identifier: NCT05336318 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients

Condition: Cancer · Psychosocial Problem  ·  Sponsor: University of Leipzig

PhaseNA
Planned participants180
Who can joinAll sexes, 18 Years to 39 Years
Healthy volunteersNo

About this study

The present bicentric study has the aim to investigate the effectiveness of the peer supported mentoring program 'Peer2Me' with regard to psychosocial parameters using a prospective Comprehensive Cohort Design. Over a period of three months, acutely ill patients in the intervention group are accompanied by a mentor with the same disease and of similar age. Patients in the control group receive a one-time consultation. Before and after the intervention, mentors and mentees are interviewed about their psychosocial distress and quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Diana Richter, PhD.  ·  +493419715438  ·  diana.richter@medizin.uni-leipzig.de

Hannah Brock  ·  +493419718824  ·  hannah.brock@medizin.uni-leipzig.de

Always discuss trial participation with your own doctor first.

Locations (2)

University Medical Center LeipzigLeipzig, Saxony, GermanyRecruiting
University Medical Center Hamburg-Eppendorf, Department of Medical PsychologyHamburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05336318